Beta
Login / Sign Up
Latest News
Earnings
Earning Calendar
Analyst Rating
Pricing
Moderna Inc. (MRNA): UBS reiterates Neutral, PT at $45
MRNA
Moderna Inc.
•
UBS
•
May 26, 2026
0
Share